Cargando…
Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors
BACKGROUND: There is ongoing search for new noninvasive biomarkers to improve management of patients with hepatocellular carcinoma (HCC). Studies, mostly from the Asian-Pacific region, demonstrated differential expression of liver-specific microRNA-122 (miR-122) in tissue as well as in sera of patie...
Autores principales: | Franck, Martin, Schütte, Kerstin, Malfertheiner, Peter, Link, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952302/ https://www.ncbi.nlm.nih.gov/pubmed/31933516 http://dx.doi.org/10.3748/wjg.v26.i1.86 |
Ejemplares similares
-
Circulating miR-21-5p level has limited prognostic value in patients with hepatocellular carcinoma and is influenced by renal function
por: Franck, Martin, et al.
Publicado: (2020) -
Development of a prognostic prediction model based on microRNA-1269a in esophageal cancer
por: Yu, Yong, et al.
Publicado: (2021) -
Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis
por: Li, Shao-Hua, et al.
Publicado: (2017) -
Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP
por: Wang, Ya-Kun, et al.
Publicado: (2018) -
Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization
por: Abuodeh, Yazan, et al.
Publicado: (2016)